Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Aimmune Therap (AIMT)

23.42 +0.16 (+0.69%)

9/20/2017  4:00pm

Open:

23.33

Pre. Close:

23.26

High:

23.58

Low:

23.01

Volume:

168,167

Market Cap:

1.18B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

23.82 - 24.29

24.29 - 24.6

Low:

22.15 - 22.28

22.28 - 22.36

Close:

23.09 - 23.59

23.59 - 23.91

Technical analysis  (as of: 2017-09-20 4:33:34 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 27.97     One year: 32.67

Support:

Support1: 20.73    Support2: 18.74

Resistance:

Resistance1: 23.95    Resistance2: 27.97

Pivot:

22.66

Moving Averages:

MA(5): 23.30     MA(20): 22.06

MA(100): 20.11     MA(250): 20.16

MACD:

MACD(12,26): 0.82     Signal(12,26,9): 0.72

%K %D:

%K(14,3): 81.26     %D(3): 82.06

RSI:

RSI(14): 70.20

52-Week:

High: 27.31  Low: 14.11  Change(%): 38.1

Average Vol(K):

3-Month: 19119  10-Days 20356

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AIMT has closed below upper band by 28.3%. Bollinger Bands are 22.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 11 Jan 2017 14:30:08 GMT
2017: A Transformational Year For Aimmune Therapeutics

Wed, 07 Jun 2017 12:00:00 GMT
Aimmune Therapeutics Cuts Ribbon on Commercial Manufacturing Facility in ...

Fri, 04 Nov 2016 14:56:35 GMT
Nestle Pays $145 Million for Stake in Biotech Firm Aimmune

Thu, 21 Sep 2017 05:26:15 GMT
Comparing Repligen Corporation (RGEN) & Aimmune Therapeutics (AIMT)

Tue, 12 Sep 2017 13:30:00 GMT
Aimmune Making Headway In Food Allergy Market

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

50.53

Shares Float (M)

26.74

% Held by Insiders

18.97

% Held by Institutions

85.51

Shares Short (K)

5100

Shares Short Prior Month (K)

5190

Stock Financials

EPS

-2.250

EPS Est. Current Year

-2.710

EPS Est. Next Year

-3.250

EPS Est. Next Quarter

-0.820

Forward EPS

-3.252

Book Value (p.s.)

4.700

PEG Ratio

0.20

Profit Margin

Operating Margin

Return on Assets (ttm)

-30.2

Return on Equity (ttm)

-50.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.102

Qtrly Earnings Growth

Operating Cash Flow (M)

-76.65

Levered Free Cash Flow (M)

-46.59

FoxReading.com

Valuation

P/E

-10.41

P/E Growth Ratio

0.01

P/BV

4.98

P/S

P/CF

-15.44

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.